| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/05/2007 | US7227031 Aspirin-triggered lipoxins as modulators of diseases associated with polymorphoneutrophil inflammation; antiinflammatory agents |
| 06/05/2007 | US7227025 Halogenation and oxidation of a 5-carboxyl-3-oxo-1-aryl-substituted-1H-pyrazolidine |
| 06/05/2007 | US7227023 Quinoline 3-amino chroman derivatives |
| 06/05/2007 | US7227022 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase |
| 06/05/2007 | US7227020 protein kinase inhibitors; asthma, psoriasis, antiinflammatory agents; inflammatory bowel disorders |
| 06/05/2007 | US7227019 Low cost, simple, high yield and purity synthesis of indolo[2,3-a]pyrrolo[3,4-c]carbazoles; oxidative cyclization of bisindolylmaleimide compounds |
| 06/05/2007 | US7227014 Oligonucleotide with 8-50 bases specifically hybridizes with a nucleic acid molecule encoding human apolipoprotein(a) and inhibits its expression |
| 06/05/2007 | US7227011 Nucleic acid vaccines for prevention of flavivirus infection |
| 06/05/2007 | US7226972 Cosmetics, drugs |
| 06/05/2007 | US7226952 Gel composition and its use in cosmetic compositions and the like |
| 06/05/2007 | US7226951 Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same |
| 06/05/2007 | US7226950 Sodium channel modulators |
| 06/05/2007 | US7226949 Such as 4,4'-thiodianiline or 4,4'-diaminobenzophenone or 4,4'-methylenedianiline |
| 06/05/2007 | US7226948 Treatment of neurodegenerative conditions with nimesulide |
| 06/05/2007 | US7226947 Use of creatine as a fat substitute |
| 06/05/2007 | US7226946 Substituted phenol compounds useful for anesthesia and sedation |
| 06/05/2007 | US7226945 Estrogen receptor-β ligands |
| 06/05/2007 | US7226944 As antitumor agent |
| 06/05/2007 | US7226943 Antilipemic agents |
| 06/05/2007 | US7226942 2-amino-4-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
| 06/05/2007 | US7226941 Compound for treating angiogenesis |
| 06/05/2007 | US7226940 Such as 3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-methoxybenzylidene-2,4-thiazolidinedione; Hodgkin's disease |
| 06/05/2007 | US7226939 Thienopyridine analogues with antifungal activity and process thereof |
| 06/05/2007 | US7226938 Heterocyclic compounds |
| 06/05/2007 | US7226937 Methods for modulating phototoxicity |
| 06/05/2007 | US7226936 Pyridinic sulfonamide derivatives method of production and use thereof |
| 06/05/2007 | US7226935 Hypoglycemic agent |
| 06/05/2007 | US7226934 Having antiallergic and anti-inflammatory effects while being devoid of the severe dose-limiting sedative side effects of ketotifen |
| 06/05/2007 | US7226933 3-[(1-benzyl-piperidin-4-yl)-(4-diethylcarbamoyl-phenyl)-amino]-benzamide used as opiod receptor agonists having improved pharmacokinetic, bioavailability, stability and/or lower toxicity; analgesisc; anxiolytic agents |
| 06/05/2007 | US7226932 Self-emulsifying drug delivery system |
| 06/05/2007 | US7226931 (R/S) rifamycin derivatives, their preparations and pharmaceutical compositions |
| 06/05/2007 | US7226930 Phosphodiesterase 4 inhibitors |
| 06/05/2007 | US7226929 drugs such as 6 -Chloro-N-{(3S)-1-[(1S)-1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide, used as antithrombotic agents |
| 06/05/2007 | US7226928 Methods for the treatment of periodontal disease |
| 06/05/2007 | US7226927 Administering 2-aryl-4- arylaminopyrimidine and analogs thereof, for therapy of disorder responsive to the induction of apoptosis in an animal suffering therefrom |
| 06/05/2007 | US7226926 8-fluoroimidazo 1,2-a pyridine derivatives as ligands for GABA receptors |
| 06/05/2007 | US7226925 Compounds, their use and preparation |
| 06/05/2007 | US7226924 Substituted 3,4-dihydro-pyrimido[1,2a]pyrimidines and 3,4-dihydro-pyrazino[1,2a]pyrimidines, and methods for their preparation and use |
| 06/05/2007 | US7226923 Phthalazinone derivatives |
| 06/05/2007 | US7226922 Imidazo[1,2-b]pyridazine analogues as anxiolytics and cognition enhancers |
| 06/05/2007 | US7226921 An enzyme inhibitor of cysteine proteases, a morpholine-4-carboxyamide 1,3,4-oxadiazole derivatives; for treating arthritis, muscular dystrophy, inflammation, tumor, glomerulonephritis, malaria, periodontal disease |
| 06/05/2007 | US7226920 Aminotriazole compounds useful as inhibitors of protein kinases |
| 06/05/2007 | US7226919 Compositions useful as inhibitors of protein kinases |
| 06/05/2007 | US7226918 DNA-PK inhibitors |
| 06/05/2007 | US7226917 Derivatives of N-[phenyl(pyrrolidine-2-yl)methyl]benzamide and N-[(azepan-2-yl)phenylmethyl]benzamide, preparation, and use in treatment of schizophrenia |
| 06/05/2007 | US7226916 For oral administration of a preparation having a) long chain polyunsaturated fatty acids, and b) specified phospholipids, and c) compounds that factor in methionine metabolism, such as folate, B vitamins, magnesium and zinc |
| 06/05/2007 | US7226915 Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors |
| 06/05/2007 | US7226914 Administering sulfated polysaccharide such as cellulose sulfate, dextran sulfate, dermatan sulfate, chondroitin sulfate, pentosan sulfate, fucoidin, mannan sulfate, dextrin sulfate, curdlan sulfate, chitin sulfate, heparin or heparin sulfate for therapy and prphylaxis of fungal infection |
| 06/05/2007 | US7226913 Pharmaceutical compositions having A2A adenosine receptor agonist activity |
| 06/05/2007 | US7226910 Treatment of female sexual dysfunction with vasoactive intestinal polypeptide agonists |
| 06/05/2007 | US7226785 A single-stranded oligonucleotide with a DNA domain having at least one mismatch with respect to genetic sequence to be altered |
| 06/05/2007 | US7226766 S-methylcysteine, S-ethylcysteine, and related S-alkylthiols as antagonists to the effects of S-nitrosothiols and nitric oxide |
| 06/05/2007 | US7226758 glial derived neurotrophic factor (GDNF) isolated from serum-free growth conditioned medium of glioblastoma cells; for preventing and treating nerve damage and nerve related diseases such as Parkinson's disease; genetic engineering |
| 06/05/2007 | US7226625 Identification of compositions, compositions, and methods of treatment of obesity and overweight conditions |
| 06/05/2007 | US7226616 Positively charged amphiphilic block copolymer as drug carrier and complex thereof with negatively charged drug |
| 06/05/2007 | US7226614 segmented; sustained release; for treatment of allergies |
| 06/05/2007 | US7226611 Glycosaminoglycan/collagen complexes and use thereof |
| 06/05/2007 | US7226609 with acetic acid inactivate the infectability of infectious proteins such as prions under relatively mild conditions |
| 06/05/2007 | US7226596 Metalloenzymes; antiproliferative agents; anticarcinogenic agents; cancer diagnosis; antisense agents; complementary determining regions |
| 06/05/2007 | US7226591 Nucleotide sequences coding protein for use in the prevention and treatment of pancreatitis |
| 06/05/2007 | US7226590 Antimicrobial composition |
| 06/05/2007 | US7226586 Biocompatible polymer designed to release nitric oxide; extensively cross-linked polyamine-derivatized divinylbenzene; sustained release, potentiation |
| 06/05/2007 | US7226582 Additive for a bodywash; after an application of the bodywash to skin and rinsing, the skin is protected from sunlight with an SPF of 5 for at least 4 hours |
| 06/05/2007 | US7226581 Bodywashes containing additives |
| 06/05/2007 | CA2411671C Inhibitors of alpha l beta 2 mediated cell adhesion |
| 06/05/2007 | CA2404703C Novel crystal form of pyrrolidylthiocarbapenem derivative |
| 06/05/2007 | CA2402201C Method of preparing clarithromycin of form ii crystals |
| 06/05/2007 | CA2385083C O-anisamide derivatives |
| 06/05/2007 | CA2376094C Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor (ppar) .alpha. |
| 06/05/2007 | CA2368400C Macrolides with anti-inflammatory activity |
| 06/05/2007 | CA2367658C Method for treatment of reactive arthritis or bursitis |
| 06/05/2007 | CA2356294C Pharmaceutical compositions for treating bone lesions in multiple myeloma |
| 06/05/2007 | CA2348470C Nucleosides with anti-hepatitis b virus activity |
| 06/05/2007 | CA2346201C Substance gm-95, process for producing the same and utilization thereof |
| 06/05/2007 | CA2329569C A method for testing drugs for maintaining, preventing, loss and/or recovering nerve cell function |
| 06/05/2007 | CA2294385C Treatment of diabetes with thiazolidinedione and sulphonylurea |
| 06/05/2007 | CA2293836C Polymorphic form of a tachykinin receptor antagonist |
| 06/05/2007 | CA2286003C Phosphate-binding polymer preparation |
| 06/05/2007 | CA2273823C Polypeptides encoded by a human lipase-like gene, compositions and methods |
| 06/05/2007 | CA2262847C Acylpyrroldicarboxylic acids and acylindoldicarboxylic acids and their derivatives and inhibitors of the cytosolic phospholipase a2 |
| 06/05/2007 | CA2244001C Novel steroid carbamates as potentiating agents |
| 06/05/2007 | CA2237335C The use of cholinesterase inhibitors in the treatment of xerostomia |
| 06/05/2007 | CA2225528C Novel camptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues |
| 06/05/2007 | CA2214431C Human vegf-specific antisense oligonucleotides |
| 06/05/2007 | CA2181165C Anti-fungal methods and materials |
| 06/05/2007 | CA2157586C Indoletetralins having dopaminergic activity |
| 06/05/2007 | CA2125644C Pharmaceutical compositions containing the salts of s(+)-2-(4-isobutylphenyl)propionic acid with basic aminoacids |
| 06/02/2007 | CA2565418A1 Dicationic compounds which selectively recognize g-quadruplex dna |
| 05/31/2007 | WO2007062413A2 Use of parp-1 inhibitors |
| 05/31/2007 | WO2007062410A1 Imidazole derivatives as nitric oxide synthase dimerisation inhibitor |
| 05/31/2007 | WO2007062403A2 Compositions useful for reducing nephrotoxicity and methods of use thereof |
| 05/31/2007 | WO2007062399A2 Oncogenic ras-specific cytotoxic compound and methods of use thereof |
| 05/31/2007 | WO2007062381A2 Hydrophobic elastomeric polymer chemistry device for inhibiting the growth of onychomycosis and urushiol-induced allergic contact dermatitis |
| 05/31/2007 | WO2007062370A2 Calcilytic compounds |
| 05/31/2007 | WO2007062343A2 Mitochondria-targeted antioxidant prodrugs and methods of use |
| 05/31/2007 | WO2007062342A1 Heterocyclic cetp inhibitors |
| 05/31/2007 | WO2007062339A2 Liquid formulations |
| 05/31/2007 | WO2007062338A2 Solid formulations |
| 05/31/2007 | WO2007062337A2 Crystalline forms |
| 05/31/2007 | WO2007062336A2 Salt forms |